Advertisement
Home 2015 September

Monthly Archives: September 2015

An experimental therapy for chronic lymphocytic leukemia that uses a patient's own T cells (an approach known as CTL019) may cure some patients and prolong survival in others

Long-Term Remissions of CLL in First Personalized Cell Tx Trial

0
T cells reprogrammed to contain chimeric antigen receptor targeting CD19 protein on B cells
There has been an increase in the number of American men with cancer in one breast who have surgery to remove their cancer-free breast

More Male Breast CA Patients Having Both Breasts Removed

0
Trend mirrors the one seen in women, researchers say
Imetelstat

Imetelstat Deemed Active in Myelofibrosis, Thrombocythemia

0
Responses for patients with myelofibrosis, essential thrombocythemia
From 2000 to 2010

Total Knee Replacement Procedures Up From 2000 to 2010

0
Considerable increase for men, women aged 45 years and older; higher rates for women in 2000, 2010
A U.S. appeals court has ruled that medical associations have a legal standing to represent their members and members' patients in cases against health insurance companies

Doctors Can Stand Up for Their Patients, Says Appeals Court

0
U.S. appeals court rules NY State Psychiatric Assn can bring claim on behalf of members, patients
Consumption of sugar-sweetened beverages by children is positively associated with triglyceride concentration

Sugary Beverage Intake Linked to Triglycerides in Children

0
Reduction in sugar-sweetened beverage intake over 12 months linked to increase in plasma HDL
Endovascular repair of abdominal aortic aneurysm is associated with a survival advantage for three years

Endovascular AAA Repair Improves Survival for Three Years

0
After three years, endovascular repair of abdominal aortic aneurysm linked to higher mortality
For patients with type 2 diabetes

Modest Relation Between HbA1c, Cardiovascular Events

0
No statistically significant interaction for difference seen for those with, without vascular disease
Patients with asthma may have an increased risk of developing Parkinson's disease

Asthma Linked to Increased Risk of Parkinson’s Disease

0
Greater risk of subsequent Parkinson's for patients with asthma with more frequent admissions
Varubi (rolapitant) has been approved by the U.S. Food and Drug Administration to prevent delayed phase chemotherapy-induced nausea and vomiting.

FDA Approves Varubi for Chemo-Induced Nausea, Vomiting

0
For prevention of the delayed phase of nausea, vomiting caused by chemotherapy